Country
Contract Development & Manufacturing Organizations in the United States
The deepest CDMO market in the world. Compare FDA-registered US contract manufacturers across biologics, sterile fill-finish, oral solid dose, and API — by capability, certification, and manufacturing site.
147 companies listed
Manufacturing sites in United States
The US CDMO landscape
The United States is the largest pharmaceutical manufacturing market on earth, with more FDA-registered drug-manufacturing facilities than any other country. For US-market products, a domestic CDMO collapses the regulatory distance to the FDA, removes import friction, and shortens the cold chain for temperature-sensitive biologics — advantages that compound on commercial-scale programs.
Manufacturing clusters are geographically distinct. The Boston–Cambridge corridor anchors biologics and cell & gene therapy. North Carolina's Research Triangle carries deep small-molecule and drug-product capacity. San Francisco and San Diego anchor West Coast biologics, while the I-95 mid-Atlantic and the Midwest hold large-scale sterile and oral-solid-dose plants.
The BIOSECURE Act has made US capacity a strategic question, not just a logistics one. Sponsors that previously relied on certain offshore CDMOs are actively reshoring biologics and cell-therapy work to domestic partners, tightening capacity and making early engagement with a US CDMO more important than at any point in the last decade.
Companies (147)
ADM Deerland Probiotics & Enzymes
United States
Advanced Instruments
United States
Afton Scientific
United States
AGC (AGC Biologics & AGC Pharma Chemicals)
United States
Agilent
United States
Albemarle
United States
Alcami
United States
Aldevron
United States
Almac Group
United States
Altasciences
United States
Amarex Clinical Research, LLC
United States
AmbioPharm
United States
American Injectables
United States
Ameripharma Labs
United States
AnaSpec, Inc.
United States
Aphena Pharma Solutions
United States
Applied Laboratories, Inc.
United States
A
Aptuit LLC
United States
Ardena
United States
Argenta (Animal Health CRO/CDMO)
United States
Argonaut Manufacturing Services
United States
ARL Bio Pharma
United States
Arxada (CDMO)
United States
Ascendia Pharmaceutical Solution
United States
Ashland Inc.
United States
A
AtlanticPharma LLC
United States
August Bioservices
United States
Avanti Polar Lipids (Croda Pharma)
United States
Avid Bioservices, Inc.
United States
BAP Pharma
United States
Benuvia Operations, LLC
United States
B
BestCo
United States
BioReliance (Merck KGaA, MilliporeSigma)
United States
BioSpectra, Inc.
United States
BioTechnique LLC
United States
Boiron
United States
Cambridge Isotope Laboratories, Inc.
United States
C
Cardinal Health (Clinical Supply Services)
United States
Catalent Pharma Solution
United States
Cayman Chemical Company
United States
CellReady
United States
C
Cencora (incl. World Courier & ICS)
United States
Center for Breakthrough Medicines (CBM)
United States
Charles River Laboratories
United States
C
Contract Packaging Resources (Aenova)
United States
Contract Pharmacal Corp (CPC)
United States
CSBio
United States
Curia Global, Inc.
United States
Cytovance Biologics
United States
D
DHL (Deutsche Post DHL Group)
United States
DPT Laboratories, LTD.
United States
D
DUDLEY CHEM CORP.
United States
Evonik Industries AG
United States
Exela Pharma Sciences
United States
Experic
United States
Fisher Clinical Services (Thermo Fisher)
United States
Fortis Life Sciences
United States
Fortrea
United States
FreeThink Technologies
United States
Fresenius Kabi iPSUM S.r.l.
United States
Gannet BioChem
United States
Genezen (USA)
United States
Gerresheimer AG
United States
G
Glatt Air Techniques
United States
GMP Laboratories of America, Inc.
United States
G
Goodwin Biotechnology (GBI)
United States
G
Grace Fine Chemical Manufacturing Services
United States
Grand River Aseptic Manufacturing (GRAM)
United States
H
Halo Pharmaceutical Inc.
United States
Helix Biotech, Inc.
United States
Hikma Pharmaceuticals
United States
Huvepharma
United States
INCOG Biopharma Services
United States
Ingredion Pharma Solutions
United States
Integrated DNA Technologies (IDT)
United States
Ion Labs, Inc.
United States
J‑STAR Research, Inc.
United States
Jost Chemical
United States
KBI Biopharma
United States
Kindeva Drug Delivery
United States
Kingchem Life Science LLC
United States
Lannett CDMO
United States
Latitude Pharmaceuticals Inc
United States
Lifecore Biomedical
United States
LOTTE BIOLOGICS
United States
LTS Lohmann Therapie-Systeme
United States
Made Scientific
United States
Medisca Inc.
United States
MedPharm
United States
Microsize, LLC
United States
Mikart, LLC
United States
National Resilience Inc.
United States
Nitto Avecia (incl. Nitto Avecia Pharma Services)
United States
NorthStar Medical Radioisotopes, LLC
United States
N
Norwich Pharmaceuticals (Norwich Pharma Services)
United States
Nutra-Med Packaging
United States
O
Oakwood Laboratories LLC
United States
Oxford Biomedica (OXB)
United States
P
Pace Analytical Services LLC (Pace Life Sciences)
United States
Par Health (planned spin‑off)
United States
Pharma Tech Industries
United States
P
Pharmaceutical Manufacturing Research Services (PMRS)
United States
P
Pharmaceutical Product Development LLC (PPD)
United States
P
Pharmaceutics International Inc. (Pii)
United States
Pharmaron
United States
Phlow Corporation
United States
PolyPeptide Group
United States
Praxis Packaging Solutions
United States
P
PremierPharma Ltd.
United States
ProMed Pharma
United States
Promega
United States
Purisys
United States
Pyramid Laboratories
United States
Quality Chemical Laboratories (QCL)
United States
Quotient Sciences
United States
QuVA Pharma
United States
Raritan Pharmaceuticals, Inc.
United States
Regis Custom Pharma (Regis Technologies, Inc.)
United States
Renaissance Lakewood, LLC
United States
Rentschler Biopharma
United States
Roquette
United States
Sandoz
United States
S
SAS Laboratoire Unither (Unither Pharmaceuticals)
United States
SGS
United States
Sharp (Sharp Packaging / Clinical Services)
United States
SHL Medical
United States
Siegfried Group
United States
Singota Solutions
United States
SMC Ltd.
United States
Sofgen Pharmaceuticals
United States
SOFIE
United States
Solventum
United States
Solvias
United States
S
Sovereign Pharmaceuticals, LLC
United States
SpectronRx
United States
S
Spectrum Chemical Manufacturing Corp
United States
S
STASON PHARMACEUTICALS, INC.
United States
Stira Pharmaceuticals (Sterile Injectable CDMO)
United States
Tanvex Biopharma USA, Inc
United States
Tedor Pharma Inc
United States
Texcell Group
United States
The Ritedose Corporation
United States
Tishcon Corp
United States
Tjoapack
United States
U
Univar Solutions Inc.
United States
UPM Pharmaceuticals
United States
West Pharmaceutical Services
United States
How this list is built: companies appear here when they have a manufacturing site in United States in our facilities dataset and pass the marketplace eligibility gate (pharmaceutical contract manufacturers only — CROs, equipment suppliers, and other non-manufacturers are excluded). Read the full methodology for the eligibility gates and how our ranked lists are computed.
Frequently Asked Questions
How many CDMOs are in the United States?+
CDMO Hub lists hundreds of contract manufacturers with at least one US manufacturing site — the largest single-country roster in the directory. The live count and ranked list above reflect listed manufacturing sites, not just company headquarters, so it tracks where drugs are actually made.
Are US CDMOs FDA-registered?+
US drug-manufacturing facilities must register with the FDA and are subject to routine cGMP inspection. Many also hold EU GMP certification for export to Europe. Always confirm a specific facility's registration and inspection history before contracting — registration status and the relevant product modality both matter.
How does the BIOSECURE Act affect choosing a US CDMO?+
The BIOSECURE Act restricts US government-funded programs from contracting with companies tied to certain foreign biotech firms of concern. While aimed at government work, it has accelerated a broader reshoring of biologics and cell-therapy manufacturing to US (and European) CDMOs, tightening domestic capacity.
What modalities are US CDMOs strongest in?+
US CDMOs span the full modality range, with particular depth in biologics, cell & gene therapy (Boston cluster), sterile fill-finish, and oral solid dose. For early-phase biologics and advanced therapies, the US offers the densest pool of qualified capacity globally.
Find the right CDMO in United States
Our AI Matchmaker analyzes your project requirements and matches you with qualified United States manufacturing partners. Free for buyers.